CLVT | Ticker Profile - Titan Protect

CLVT

Clarivate Plc

Technology · Information Technology Services · NYQ

$2.41

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.7B

Total market value of the company

Trailing P/E

N/A

Forward P/E

3.31

Based on estimated future earnings — lower means cheaper

Rev Growth

-1.4%

Year-over-year revenue change

Profit Margin

-5.6%

How much profit the company keeps from each dollar of revenue

ROE

-2.8%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$2.90

+20% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 7 analysts covering this stock

About Clarivate Plc

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. The company offers scientific and academic research solutions; Web of Science Research Intelligence, an AI-native solution; ProQuest solutions to access multidisciplinary curated content, such as databases, dissertations, news, primary sources, books, and video formats; library software, including Alma, library services platform; and Vega and Polaris for public libraries. It also provides patent maintenance and administrative services; Derwent Innovation, an AI-powered search; Derwent World Patents Index to identify related concepts in patent publications and navigate new or unfamiliar technology categories; CompuMark, a trademark search and watch solutions; IP Recordals managed services; and RiskMark, an AI-powered tool for evaluating trademark risk and argument drafting support. In addition, the company offers IPfolio, a management platform; FoundationIP solution for law firms; Cortellis for decisions related to assessing the market, analyzing competitors, regulatory compliance, and drug safety; Regulatory Intelligence platform; commercial solutions; and Medtech solutions. It serves academic institutions, government agencies, and life sciences, and pharmaceutical companies. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

https://www.clarivate.com

Country: United Kingdom Employees: 12,000 Industry: Information Technology Services

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

-0.323

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0824

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.430

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-32.9%

Historical annualised return based on price data

Max Drawdown

-76.3%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.41

Moves slightly more than the broader market

52W High

$4.77

49% below the year high

52W Low

$1.66

45% above the year low

Avg Volume

5,411,832

Average daily shares traded — higher means easier to buy and sell

Short Ratio

10.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

16.0%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.21

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

90.53

Heavy leverage — higher financial risk if revenues decline

Current Ratio

0.84

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.72

Like current ratio but excludes inventory — stricter test

Gross Margin

66.5%

Revenue left after cost of goods — higher means pricing power

Operating Margin

5.1%

Profit from core operations before interest and tax

Free Cash Flow

$473M

Positive — the business generates more cash than it spends

Revenue (TTM)

$2.4B

Total revenue over the last 12 months

Net Income

$-137,400,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$6.00

Target Median

$2.90

Target Low

$2.40

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go